Use of taurolidine formulations for the intramammary treatment of mastitis
The invention is directed to the use of a formulation containing taurolidine and one or more vehicles for preparing a veterinary medical composition for intramammary treatment of mastitis or the prevention thereof. The intramammary administration leads to an effective concentration in the target tis...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention is directed to the use of a formulation containing taurolidine and one or more vehicles for preparing a veterinary medical composition for intramammary treatment of mastitis or the prevention thereof. The intramammary administration leads to an effective concentration in the target tissue, which is achieved very quickly. The taurolidine formulation used according to the present invention is the first product for the treatment of clinical, subclinical and chronic mastitis without residues, without a significant withdrawal period and without the resistance induction image of classical antibiotics. |
|---|